UroGen Pharma Ltd. Quarterly Other Assets, Noncurrent in USD from Q4 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
UroGen Pharma Ltd. quarterly Other Assets, Noncurrent history and growth rate from Q4 2016 to Q3 2024.
  • UroGen Pharma Ltd. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $370K, a 82% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $370K -$1.68M -82% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $673K -$2.14M -76.1% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $1.1M -$2.06M -65.3% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $2.04M -$702K -25.6% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 $2.05M -$421K -17% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $2.82M +$917K +48.3% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $3.16M +$1.59M +101% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $2.74M +$1.43M +109% Dec 31, 2022 10-K 2024-03-14
Q3 2022 $2.47M +$698K +39.4% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $1.9M +$797K +72.3% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $1.57M +$1.51M +2282% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $1.31M +$1.25M +1886% Dec 31, 2021 10-K 2023-03-24
Q3 2021 $1.77M +$1.72M +3124% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $1.1M Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $66K -$213K -76.3% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $66K -$198K -75% Dec 31, 2020 10-K 2022-03-21
Q3 2020 $55K -$2.37M -97.7% Sep 30, 2020 10-Q 2020-11-09
Q1 2020 $279K -$2.5M -90% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $264K -$53K -16.7% Dec 31, 2019 10-K 2021-03-18
Q3 2019 $2.42M +$2.41M +17207% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $2.56M Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $2.78M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $317K +$73K +29.9% Dec 31, 2018 10-K 2020-03-02
Q3 2018 $14K Sep 30, 2018 6-K 2018-11-13
Q4 2017 $244K -$6K -2.4% Dec 31, 2017 10-K 2019-02-28
Q4 2016 $250K Dec 31, 2016 20-F 2018-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.